Shilpa Medicare Limited — Financials & Forensics
Sector: Healthcare · NSE: SHILPAMED · BSE: 530549 · ISIN: INE790G01031
17 Nov 2026
Add SHILPAMED to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹830 Cr | ₹1,146 Cr | ₹1,050 Cr | ₹1,152 Cr | ₹1,539 Cr |
| EBITDA | ₹227 Cr | ₹204 Cr | ₹102 Cr | ₹244 Cr | ₹435 Cr |
| EBITDA margin | 27.3% | 17.8% | 9.7% | 21.2% | 28.2% |
| Profit after tax | ₹184 Cr | ₹61 Cr | ₹-32 Cr | ₹32 Cr | ₹243 Cr |
Deeper analysis
Recent filings by Shilpa Medicare Limited
-
Analysts/Institutional Investor Meet/Con. Call Updates
05 Nov 2026 · General Update
-
Outcome of Board Meeting
05 Nov 2026 · Financial Results
-
Analysts/Institutional Investor Meet/Con. Call Updates
29 Oct 2026 · General Update
-
Board Meeting Intimation
29 Oct 2026 · Board Meeting
-
Europe GMP approval of Shilpa Medicare Limited. Unit 4, Jadcherla, Telangana.
10 Oct 2026 · Regulatory Compliance
Never miss a filing again
About Shilpa Medicare Limited on Indian Stock Alerts
Indian Stock Alerts tracks Shilpa Medicare Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.